octreotide

Octreotide (SMS 201-995) is a potent inhibitor of growth hormone, glucagon, and insulin.

Octreotide Acetate (Sandostatin) is a potent, long-acting synthetic somatostatin octapeptide analog that inhibits secretion of growth hormone.

Octreotide HCl is a potent, long-acting synthetic SOMATOSTATIN octapeptide analog that inhibits the secretion of growth hormone.

Octreotide pamoate is an antineoplastic agent.

3-Tyr-octreotide is a biochemical that has been evaluated for tumor inhibition.

Octreotide, a cyclic SSTR agonist, serves as the cyclic Somatostatin Receptor SSTR agonist [1].

Acetyl-Lys5-octreotide is a biologically active peptide [1].

DSPE-PEG3400-Octreotide is a PEG compound composed of DSPE and Octreotide. Octreotide acts as a somatostatin receptor agonist with antitumor properties and mediates apoptosis, and it is also applicable in the study of acromegaly. DSPE-PEG3400-Octreotide can be utilized for drug delivery purposes.

DOTA-Octreotide TFA consists of the chelating agent DOTA and Octreotide. It is utilized in cancer research through its ability to bind with radioactive elements and is also employed in the synthesis and study of radiolabeled conjugate drugs (RDC).

Des-threoninol-octreotide (Compound 13) is a somatostatin analogue with inhibitory effects on cloned somatostatin receptors. It exhibits IC50 values of 13.62 nM for mSSTR2b, 10.63 nM for rSSTR5, and 10.95 nM for hSSTR5.

DSPE-PEG1000-Octreotide, a PEG compound formed from DSPE and Octreotide, acts as a somatostatin receptor agonist. Octreotide exhibits antitumor properties and induces apoptosis, making it useful in researching acromegaly. Additionally, DSPE-PEG1000-Octreotide is applicable in drug delivery.

DSPE-PEG2000-Octreotide is a PEG compound composed of DSPE and Octreotide. Octreotide serves as a somatostatin receptor agonist with antitumor properties, mediating apoptosis and applicable in acromegaly research. DSPE-PEG2000-Octreotide is employed in drug delivery systems.

DSPE-PEG5000-Octreotide is a PEG compound composed of DSPE and Octreotide. Octreotide serves as a somatostatin receptor agonist and exhibits anti-tumor properties, induces apoptosis, and is applicable for acromegaly research. DSPE-PEG5000-Octreotide can be utilized in drug delivery.

Octreotide Acetate (Standard) is a reference standard for research and analysis in studies involving Octreotide Acetate. Octreotide Acetate (Sandostatin) is a potent, long-acting synthetic somatostatin octapeptide analog that inhibits secretion of growth hormone.

Octreotide-[D8] Acetate Salt (Standard) is a reference standard of Octreotide-[D8] Acetate Salt intended for quantitative analysis, quality control, and related biochemical research applications.

Dotanoc is a ligand to make gallium Ga 68-DOTANOC, which is a gallium Ga 68-radiolabeled analog of somatostatin.

Pentetreotide is an indium-labeled somatostatin analog and can be used for nuclear medicine imaging. Pentetreotide is a diethylenetriaminopentaacetic conjugate of Octreotide. Somatostatin receptor scintigraphy with Pentetreotide is effective in visualizin

Veldoreotide (DG3173) TFA, a somatostatin analogue, effectively binds to and activates somatostatin receptors (SSTR) 2, 4, and 5. This compound demonstrates a higher efficacy in inhibiting growth hormone (GH) secretion in adenomas than Octreotide, showcasing its potential as a pain modulating agent [1].

Ilatreotide is a Amadori compound of octreotide.

Veldoreotide, also known as Somatoprim, is a unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue which effectively reduces GH secretion in human GH-secreting pituitary adenomas, even in Octreotide non-responsive tumours.

Alkyne-βAG-TOCA is an octreotide derivative that targets somatostatin receptor subtype 2 (SST2). It is utilized in the synthesis and research of radioconjugates (RDC).